JPWO2022059602A1 - - Google Patents

Info

Publication number
JPWO2022059602A1
JPWO2022059602A1 JP2022550517A JP2022550517A JPWO2022059602A1 JP WO2022059602 A1 JPWO2022059602 A1 JP WO2022059602A1 JP 2022550517 A JP2022550517 A JP 2022550517A JP 2022550517 A JP2022550517 A JP 2022550517A JP WO2022059602 A1 JPWO2022059602 A1 JP WO2022059602A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022550517A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022059602A1 publication Critical patent/JPWO2022059602A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
    • G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
    • G01T1/16—Measuring radiation intensity
    • G01T1/161—Applications in the field of nuclear medicine, e.g. in vivo counting

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine (AREA)
JP2022550517A 2020-09-16 2021-09-10 Pending JPWO2022059602A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020155789 2020-09-16
PCT/JP2021/033231 WO2022059602A1 (en) 2020-09-16 2021-09-10 Biological information acquisition method

Publications (1)

Publication Number Publication Date
JPWO2022059602A1 true JPWO2022059602A1 (en) 2022-03-24

Family

ID=80777015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022550517A Pending JPWO2022059602A1 (en) 2020-09-16 2021-09-10

Country Status (2)

Country Link
JP (1) JPWO2022059602A1 (en)
WO (1) WO2022059602A1 (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7545910B2 (en) * 2003-03-07 2009-06-09 Koninklijke Philips Electronics N.V. Method and imaging system for imaging the spatial distribution of an x-ray fluorescence marker
JP2006133205A (en) * 2004-11-05 2006-05-25 Cellgen Kk Method of understanding distribution of curative cell in living body
EP1825881A1 (en) * 2006-07-27 2007-08-29 BrainLAB AG Simulating the distribution of therapeutic or diagnostic agents in a subject
JP5457191B2 (en) * 2006-11-14 2014-04-02 コーニンクレッカ フィリップス エヌ ヴェ System, method and computer program for determining the distribution of a radiopharmaceutical in a subject
JP4907591B2 (en) * 2008-04-08 2012-03-28 株式会社日立製作所 ESR contrast agent and method for producing the same
WO2010119485A1 (en) * 2009-04-16 2010-10-21 株式会社島津製作所 Radiation tomographic device
CN110841078A (en) * 2012-03-05 2020-02-28 伯拉考成像股份公司 Dynamic enhanced MRI imaging method and active agent for evaluating macromolecular transport in pathological tissues
US11633502B2 (en) * 2016-03-07 2023-04-25 Memorial Sloan Kettering Cancer Center Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use
US10973486B2 (en) * 2018-01-08 2021-04-13 Progenics Pharmaceuticals, Inc. Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
JP2020060544A (en) * 2018-10-04 2020-04-16 国立大学法人大阪大学 Safety evaluation method for alpha-ray nuclear medicine treatment agent and screening method
US11744908B2 (en) * 2018-10-25 2023-09-05 John Christoforidis Methods for determining biodistribution of intravitreal administered medicaments
WO2020122102A1 (en) * 2018-12-14 2020-06-18 コニカミノルタ株式会社 Method for forecasting arrival of drug inside diseased tissue

Also Published As

Publication number Publication date
WO2022059602A1 (en) 2022-03-24

Similar Documents

Publication Publication Date Title
BR112023005462A2 (en)
BR112021014123A2 (en)
BR112023012656A2 (en)
BR112022009896A2 (en)
BR112022024743A2 (en)
BR112023009656A2 (en)
BR102021018859A2 (en)
BR102021015500A2 (en)
BR102021007058A2 (en)
BR102020022030A2 (en)
BR112023011738A2 (en)
BR112023016292A2 (en)
BR112023004146A2 (en)
BR112023011539A2 (en)
BR112023011610A2 (en)
BR112023008976A2 (en)
BR112023006729A2 (en)
BR102021020147A2 (en)
BR102021018926A2 (en)
BR102021018167A2 (en)
BR102021017576A2 (en)
BR102021016837A2 (en)
BR102021016551A2 (en)
BR102021016375A2 (en)
BR102021016200A2 (en)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231222